Last updated: August 1, 2025
Introduction
South Korea patent KR20090117924, filed in 2009, pertains to innovative pharmaceutical compounds with potential therapeutic applications. This patent exemplifies South Korea’s vibrant drug patent landscape, which emphasizes protection of novel chemical entities, formulation methods, and method-of-use claims. A detailed review of this patent’s scope and claims, alongside an overview of the broader patent landscape, provides insights into strategic patenting practices, competitive positioning, and potential areas of innovation within the pharmaceutical sector in Korea.
Scope and Core Claims of KR20090117924
1. Overview of Patent Content
KR20090117924 claims a specific chemical compound or class of compounds with therapeutic utility, alongside methods for their synthesis and use in treating particular medical conditions. The chemical structure, as described, likely includes key functional groups designed to modulate biological targets.
2. Key Claims Analysis
-
Chemical Compound Claims:
The patent broadly claims the chemical entity or family of compounds characterized by specific substituents and structural features. Such claims aim to secure exclusive rights over the novel chemical structure, preventing generic or identical compounds from entering the market.
-
Method of Synthesis:
Claims extend to novel synthetic routes, which may offer advantages in yield, purity, or scalability, thus establishing a competitive edge in manufacturing.
-
Pharmacological Use Claims:
Use claims cover the application of the compound in treating a defined disease, such as cancer, neurodegenerative conditions, or infectious diseases. These are often articulated as "method of use" claims to secure protection for essential therapeutic applications.
-
Formulation Claims:
The patent also potentially covers pharmaceutical compositions containing the compound, including dosage forms, excipient combinations, or delivery mechanisms.
3. Claim Strategy and Scope
The patent employs orphaned claims—broad enough to cover various structural analogs—while maintaining specificity through detailed structural parameters. This strategy maximizes protection scope, deterring design-arounds, and extending the patent's lifespan.
Patent Landscape and Market Context
1. South Korea’s Pharmaceutical Patent Environment
South Korea maintains a dynamic patent environment supported by a robust innovation ecosystem. The patent landscape favors early-stage filings, with a keen interest in chemical and biologic therapeutic inventions. The patent office emphasizes clear claim language and detailed specifications, aligning with international standards.
2. Active Patent Filings in Targeted Therapeutic Areas
Korean companies and research institutions actively patent compounds similar to KR20090117924 in therapeutic areas such as oncology, neurology, and infectious diseases. The patent’s filing date places it amid a surge of innovation in targeted therapies, reflecting strategic positioning within competitive markets.
3. Patent Families and International Filings
KR20090117924 is part of a broader patent family, with counterparts filed in major jurisdictions via PCT applications or direct filings. This global approach aims to secure market exclusivity in key regions, including the U.S., Europe, and Asia.
4. Competitive Innovation and Legal Landscape
Legal challenges, including patent oppositions, are common in Korea. Companies typically bolster these patents with data exclusivity and supplementary protection certificates (SPCs). The patent landscape features active patent infringement litigation, especially concerning overlapping claims or generic challenges.
Scope and Claims Strengths & Weaknesses
Strengths:
-
Detailed structural claims afford strong protection over specific compounds.
-
Use claims provide therapeutically relevant protection, expanding coverage beyond compounds alone.
-
Method claims for synthesis add layers of protection, deterring competitors from manufacturing similar compounds through alternative routes.
Weaknesses:
-
Claims may be vulnerable if broader prior art exists, limiting scope.
-
The specificity of structure claims could be circumvented by minor chemical modifications, necessitating ongoing innovation or additional patents.
-
Use claims require robust clinical data to defend their validity, which may be resource-intensive.
Strategic Implications for Stakeholders
For Innovators:
This patent exemplifies a comprehensive approach, covering chemical, synthesis, and use claims, indicating a strategic effort to establish broad and defensible IP rights. Patent owners should monitor potential infringing compounds, especially structurally similar analogs, and prepare for lifecycle management via continuations or divisions.
For Generic Manufacturers:
Understanding the scope reveals potential avenues for designing non-infringing alternatives, such as novel modifications or different therapeutic methods. Careful patent landscape analysis is essential to navigate around such claims.
For Patent Practitioners:
Ensuring claims are adequately supported by experimental data and adequately broad without overreach is vital for enforceability and durability, especially in a competitive jurisdiction like Korea.
Conclusion and Key Takeaways
KR20090117924 represents a strategic patent application within Korea’s pharmaceutical patent landscape. Its comprehensive scope, covering chemical structures, synthesis, and therapeutic use, exemplifies best practices in drug patenting. Stakeholders must consider this patent’s claims in developing or navigating similar innovations, emphasizing the importance of robust patent drafting, strategic claim expansion, and lifecycle management.
Key Takeaways
-
Broad Claim Strategy: The patent secures protection across multiple claim categories—chemical, synthesis, and use—strengthening market exclusivity.
-
Landscape Alignment: It aligns with South Korea’s emphasis on chemical patent robustness and strategic protection of therapeutics, especially in high-growth areas like targeted therapy and chemical biology.
-
Competitive Positioning: Close monitoring of similar patents and possible infringement efforts are essential, given Korea’s active enforcement environment.
-
Lifecycle Management: Continuous innovation and filing of divisional or continuation patents are critical to maintain market dominance as fundamental claims face potential challenges.
-
Global Considerations: Filing in multiple jurisdictions, including PCT routes, enhances the patent portfolio’s global strength and commercial viability.
FAQs
Q1: How does KR20090117924 compare to other pharmaceutical patents filed in Korea during the same period?
A1: It exemplifies a comprehensive patent approach, with broad chemical, synthesis, and use claims comparable to industry standards, providing robust market protection amid rising innovation and patent filings in Korea’s biotech sector.
Q2: Can minor chemical modifications circumvent the claims of KR20090117924?
A2: Yes, if they fall outside the specific structural scope claimed, companies can develop analogs. However, claims can be amended or new patents filed to cover such modifications.
Q3: What are common challenges in enforcing this patent in Korea’s courts?
A3: Challenges include proving infringement if modifications are employed, navigating prior art, and defending the patent’s validity through evidence of inventiveness and clear novelty.
Q4: Is it advantageous to pursue international patent protection for the compounds claimed in KR20090117924?
A4: Yes, especially in key markets like the U.S., Europe, and China, to maximize market exclusivity and deter generic competition globally.
Q5: How are patent landscapes evolving for chemically synthesized drugs in Korea?
A5: They are increasingly complex, with a focus on broad, well-supported claims, lifecycle management, and strategic filings to navigate patent thickets and opposition proceedings effectively.
Sources:
[1] Korean Intellectual Property Office (KIPO) patent database
[2] South Korean patent law and practice guidelines
[3] Industry reports on pharmaceutical patent trends in Korea
